Literature DB >> 21892161

Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.

Adam J Bass1,2,3,4, Michael S Lawrence4, Lear E Brace1, Alex H Ramos1,4, Yotam Drier5, Kristian Cibulskis4, Carrie Sougnez4, Douglas Voet4, Gordon Saksena4, Andrey Sivachenko4, Rui Jing4, Melissa Parkin4, Trevor Pugh1,4, Roel G Verhaak1,4, Nicolas Stransky4, Adam T Boutin1, Jordi Barretina4, David B Solit6, Evi Vakiani7, Wenlin Shao8, Yuji Mishina8, Markus Warmuth8, Jose Jimenez9, Derek Y Chiang10, Sabina Signoretti11,12, William G Kaelin1,2, Nicole Spardy1, William C Hahn1,2,3,4, Yujin Hoshida4, Shuji Ogino1,11,12,13, Ronald A DePinho1,2,14,15, Lynda Chin1,4,15,16, Levi A Garraway1,2,3,4, Charles S Fuchs1,2,13, Jose Baselga9,17, Josep Tabernero9, Stacey Gabriel4, Eric S Lander4,18,19, Gad Getz4, Matthew Meyerson1,3,4,11.   

Abstract

Prior studies have identified recurrent oncogenic mutations in colorectal adenocarcinoma and have surveyed exons of protein-coding genes for mutations in 11 affected individuals. Here we report whole-genome sequencing from nine individuals with colorectal cancer, including primary colorectal tumors and matched adjacent non-tumor tissues, at an average of 30.7× and 31.9× coverage, respectively. We identify an average of 75 somatic rearrangements per tumor, including complex networks of translocations between pairs of chromosomes. Eleven rearrangements encode predicted in-frame fusion proteins, including a fusion of VTI1A and TCF7L2 found in 3 out of 97 colorectal cancers. Although TCF7L2 encodes TCF4, which cooperates with β-catenin in colorectal carcinogenesis, the fusion lacks the TCF4 β-catenin-binding domain. We found a colorectal carcinoma cell line harboring the fusion gene to be dependent on VTI1A-TCF7L2 for anchorage-independent growth using RNA interference-mediated knockdown. This study shows previously unidentified levels of genomic rearrangements in colorectal carcinoma that can lead to essential gene fusions and other oncogenic events.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21892161      PMCID: PMC3802528          DOI: 10.1038/ng.936

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  39 in total

1.  Circos: an information aesthetic for comparative genomics.

Authors:  Martin Krzywinski; Jacqueline Schein; Inanç Birol; Joseph Connors; Randy Gascoyne; Doug Horsman; Steven J Jones; Marco A Marra
Journal:  Genome Res       Date:  2009-06-18       Impact factor: 9.043

2.  The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.

Authors:  Sari Tuupanen; Mikko Turunen; Rainer Lehtonen; Outi Hallikas; Sakari Vanharanta; Teemu Kivioja; Mikael Björklund; Gonghong Wei; Jian Yan; Iina Niittymäki; Jukka-Pekka Mecklin; Heikki Järvinen; Ari Ristimäki; Mariachiara Di-Bernardo; Phil East; Luis Carvajal-Carmona; Richard S Houlston; Ian Tomlinson; Kimmo Palin; Esko Ukkonen; Auli Karhu; Jussi Taipale; Lauri A Aaltonen
Journal:  Nat Genet       Date:  2009-06-28       Impact factor: 38.330

3.  T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis.

Authors:  Melinda L Angus-Hill; Kathryn M Elbert; Julio Hidalgo; Mario R Capecchi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

4.  The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.

Authors:  Mark M Pomerantz; Nasim Ahmadiyeh; Li Jia; Paula Herman; Michael P Verzi; Harshavardhan Doddapaneni; Christine A Beckwith; Jennifer A Chan; Adam Hills; Matt Davis; Keluo Yao; Sarah M Kehoe; Heinz-Josef Lenz; Christopher A Haiman; Chunli Yan; Brian E Henderson; Baruch Frenkel; Jordi Barretina; Adam Bass; Josep Tabernero; José Baselga; Meredith M Regan; J Robert Manak; Ramesh Shivdasani; Gerhard A Coetzee; Matthew L Freedman
Journal:  Nat Genet       Date:  2009-06-28       Impact factor: 38.330

5.  High-resolution mapping of copy-number alterations with massively parallel sequencing.

Authors:  Derek Y Chiang; Gad Getz; David B Jaffe; Michael J T O'Kelly; Xiaojun Zhao; Scott L Carter; Carsten Russ; Chad Nusbaum; Matthew Meyerson; Eric S Lander
Journal:  Nat Methods       Date:  2008-11-30       Impact factor: 28.547

6.  Initial genome sequencing and analysis of multiple myeloma.

Authors:  Michael A Chapman; Michael S Lawrence; Jonathan J Keats; Kristian Cibulskis; Carrie Sougnez; Anna C Schinzel; Christina L Harview; Jean-Philippe Brunet; Gregory J Ahmann; Mazhar Adli; Kenneth C Anderson; Kristin G Ardlie; Daniel Auclair; Angela Baker; P Leif Bergsagel; Bradley E Bernstein; Yotam Drier; Rafael Fonseca; Stacey B Gabriel; Craig C Hofmeister; Sundar Jagannath; Andrzej J Jakubowiak; Amrita Krishnan; Joan Levy; Ted Liefeld; Sagar Lonial; Scott Mahan; Bunmi Mfuko; Stefano Monti; Louise M Perkins; Robb Onofrio; Trevor J Pugh; S Vincent Rajkumar; Alex H Ramos; David S Siegel; Andrey Sivachenko; A Keith Stewart; Suzanne Trudel; Ravi Vij; Douglas Voet; Wendy Winckler; Todd Zimmerman; John Carpten; Jeff Trent; William C Hahn; Levi A Garraway; Matthew Meyerson; Eric S Lander; Gad Getz; Todd R Golub
Journal:  Nature       Date:  2011-03-24       Impact factor: 49.962

7.  Massive genomic rearrangement acquired in a single catastrophic event during cancer development.

Authors:  Philip J Stephens; Chris D Greenman; Beiyuan Fu; Fengtang Yang; Graham R Bignell; Laura J Mudie; Erin D Pleasance; King Wai Lau; David Beare; Lucy A Stebbings; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Michael A Quail; John Burton; Harold Swerdlow; Nigel P Carter; Laura A Morsberger; Christine Iacobuzio-Donahue; George A Follows; Anthony R Green; Adrienne M Flanagan; Michael R Stratton; P Andrew Futreal; Peter J Campbell
Journal:  Cell       Date:  2011-01-07       Impact factor: 41.582

8.  LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer.

Authors:  Lydia Kriegl; David Horst; Jana A Reiche; Jutta Engel; Thomas Kirchner; Andreas Jung
Journal:  J Transl Med       Date:  2010-11-22       Impact factor: 5.531

9.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

10.  DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.

Authors:  Timothy J Ley; Elaine R Mardis; Li Ding; Bob Fulton; Michael D McLellan; Ken Chen; David Dooling; Brian H Dunford-Shore; Sean McGrath; Matthew Hickenbotham; Lisa Cook; Rachel Abbott; David E Larson; Dan C Koboldt; Craig Pohl; Scott Smith; Amy Hawkins; Scott Abbott; Devin Locke; Ladeana W Hillier; Tracie Miner; Lucinda Fulton; Vincent Magrini; Todd Wylie; Jarret Glasscock; Joshua Conyers; Nathan Sander; Xiaoqi Shi; John R Osborne; Patrick Minx; David Gordon; Asif Chinwalla; Yu Zhao; Rhonda E Ries; Jacqueline E Payton; Peter Westervelt; Michael H Tomasson; Mark Watson; Jack Baty; Jennifer Ivanovich; Sharon Heath; William D Shannon; Rakesh Nagarajan; Matthew J Walter; Daniel C Link; Timothy A Graubert; John F DiPersio; Richard K Wilson
Journal:  Nature       Date:  2008-11-06       Impact factor: 49.962

View more
  173 in total

Review 1.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

2.  How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?

Authors:  Kristen K Ciombor; Sigurdis Haraldsdottir; Richard M Goldberg
Journal:  Curr Colorectal Cancer Rep       Date:  2014-12-01

Review 3.  Patterns of Chromosomal Aberrations in Solid Tumors.

Authors:  Marian Grade; Michael J Difilippantonio; Jordi Camps
Journal:  Recent Results Cancer Res       Date:  2015

4.  The novel fusion transcript NR5A2-KLHL29FT is generated by an insertion at the KLHL29 locus.

Authors:  Zhenguo Sun; Xiquan Ke; Steven L Salzberg; Daehwan Kim; Valentin Antonescu; Yulan Cheng; Binbin Huang; Jee Hoon Song; John M Abraham; Sariat Ibrahim; Hui Tian; Stephen J Meltzer
Journal:  Cancer       Date:  2017-01-12       Impact factor: 6.860

Review 5.  Emerging patterns of somatic mutations in cancer.

Authors:  Ian R Watson; Koichi Takahashi; P Andrew Futreal; Lynda Chin
Journal:  Nat Rev Genet       Date:  2013-09-11       Impact factor: 53.242

6.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma.

Authors:  Aleksandar D Kostic; Dirk Gevers; Chandra Sekhar Pedamallu; Monia Michaud; Fujiko Duke; Ashlee M Earl; Akinyemi I Ojesina; Joonil Jung; Adam J Bass; Josep Tabernero; José Baselga; Chen Liu; Ramesh A Shivdasani; Shuji Ogino; Bruce W Birren; Curtis Huttenhower; Wendy S Garrett; Matthew Meyerson
Journal:  Genome Res       Date:  2011-10-18       Impact factor: 9.043

7.  Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators.

Authors:  Tomomitsu Tahara; Eiichiro Yamamoto; Priyanka Madireddi; Hiromu Suzuki; Reo Maruyama; Woonbok Chung; Judith Garriga; Jaroslav Jelinek; Hiro-O Yamano; Tamotsu Sugai; Yutaka Kondo; Minoru Toyota; Jean-Pierre J Issa; Marcos R H Estécio
Journal:  Gastroenterology       Date:  2013-11-06       Impact factor: 22.682

Review 8.  WNT signalling pathways as therapeutic targets in cancer.

Authors:  Jamie N Anastas; Randall T Moon
Journal:  Nat Rev Cancer       Date:  2013-01       Impact factor: 60.716

9.  Single nucleotide polymorphism array analysis of microsatellite-stable, diploid/near-diploid colorectal carcinomas without the CpG island methylator phenotype.

Authors:  Michael Linnebacher; Christiane Ostwald; Dirk Koczan; Tareq Salem; Björn Schneider; Mathias Krohn; Mathias Ernst; Friedrich Prall
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

Review 10.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.